Bacterial meningitis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
m Bot: Removing from Primary care |
||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no specific secondary prevention strategies for bacterial meningitis. However, secondary prevention stratgies which may help prevent complications, morbidity, mortality and secondary cases may include early diagnosis and treatment, identification of specific pathogen and pathogen directed therapy, admission and constant monitoring of patients prone to develop complications. Chemoprophylaxis with rifampicin for carriers and suspected cases may help to develop full blown disease. | There are no specific secondary prevention strategies for bacterial meningitis. However, secondary prevention stratgies which may help prevent complications, morbidity, mortality and secondary cases may include early diagnosis and treatment, identification of specific pathogen and pathogen directed therapy, admission and constant monitoring of patients prone to develop complications. Chemoprophylaxis with rifampicin for carriers and suspected cases may help to develop full blown disease.<ref name=abc>Mayon-White, R. T., and P. T. Heath. "Preventative strategies on meningococcal disease." Archives of disease in childhood 76.3 (1997): 178-181.Accessed on 6th Jan, 2017</ref><ref name="pmid15178612">{{cite journal| author=Purcell B, Samuelsson S, Hahné SJ, Ehrhard I, Heuberger S, Camaroni I et al.| title=Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. | journal=BMJ | year= 2004 | volume= 328 | issue= 7452 | pages= 1339 | pmid=15178612 | doi=10.1136/bmj.328.7452.1339 | pmc=420283 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15178612 }} </ref> | ||
==Secondary prevention== | ==Secondary prevention== | ||
Secondary prevention strategies for to prevent complications and significant morbidity may include: | Secondary prevention strategies for to prevent complications and significant morbidity may include:<ref name=abc>Mayon-White, R. T., and P. T. Heath. "Preventative strategies on meningococcal disease." Archives of disease in childhood 76.3 (1997): 178-181.Accessed on 6th Jan, 2017</ref><ref name="pmid15178612">{{cite journal| author=Purcell B, Samuelsson S, Hahné SJ, Ehrhard I, Heuberger S, Camaroni I et al.| title=Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. | journal=BMJ | year= 2004 | volume= 328 | issue= 7452 | pages= 1339 | pmid=15178612 | doi=10.1136/bmj.328.7452.1339 | pmc=420283 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15178612 }} </ref><ref name="pmid11668937">{{cite journal| author=Ahlawat S, Kumar R, Roy P, Varma S, Sharma BK| title=Meningococcal meningitis outbreak control strategies. | journal=J Commun Dis | year= 2000 | volume= 32 | issue= 4 | pages= 264-74 | pmid=11668937 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11668937 }} </ref> | ||
*Early diagnosis and initiation of treatment | *Early diagnosis and initiation of treatment | ||
* | *Admission and constant monitoring in patients susceptible to develop complications | ||
*Chemoprophylaxis for suspected cases or carriers | *Chemoprophylaxis for suspected cases or carriers of Hemophilus influenza and Neisseria meningitidis | ||
==References== | ==References== | ||
| Line 17: | Line 17: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 20:34, 29 July 2020
|
Bacterial meningitis Microchapters |
|
Diagnosis |
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
There are no specific secondary prevention strategies for bacterial meningitis. However, secondary prevention stratgies which may help prevent complications, morbidity, mortality and secondary cases may include early diagnosis and treatment, identification of specific pathogen and pathogen directed therapy, admission and constant monitoring of patients prone to develop complications. Chemoprophylaxis with rifampicin for carriers and suspected cases may help to develop full blown disease.[1][2]
Secondary prevention
Secondary prevention strategies for to prevent complications and significant morbidity may include:[1][2][3]
- Early diagnosis and initiation of treatment
- Admission and constant monitoring in patients susceptible to develop complications
- Chemoprophylaxis for suspected cases or carriers of Hemophilus influenza and Neisseria meningitidis
References
- ↑ 1.0 1.1 Mayon-White, R. T., and P. T. Heath. "Preventative strategies on meningococcal disease." Archives of disease in childhood 76.3 (1997): 178-181.Accessed on 6th Jan, 2017
- ↑ 2.0 2.1 Purcell B, Samuelsson S, Hahné SJ, Ehrhard I, Heuberger S, Camaroni I; et al. (2004). "Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review". BMJ. 328 (7452): 1339. doi:10.1136/bmj.328.7452.1339. PMC 420283. PMID 15178612.
- ↑ Ahlawat S, Kumar R, Roy P, Varma S, Sharma BK (2000). "Meningococcal meningitis outbreak control strategies". J Commun Dis. 32 (4): 264–74. PMID 11668937.